Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus

Journal of General Virology

Volumn 80, Issue 8, 1999, Pages 2193-2203

  Speck, Peter ^a   Kline, Kimberly A ^a   Cheresh, Paul ^a   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL IMMORTALIZATION; DELETION MUTANT; EPSTEIN BARR VIRUS; GENE DELETION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION; VIRUS RECOMBINANT;

ANIMALIA; DNA VIRUSES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 0032771587     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-8-2193     Document Type: Article

References (46)

1. Brielmeier, M., Mautner, J., Laux, G. & Hammerschmidt, W. (1996). The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization. Journal of General Virology 77, 2807-2818.
2. Burkhardt, A. L., Bolen, J. B., Kieff, E. & Longnecker, R. (1992). An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. Journal of Virology 66, 5161-5167.
3. Caldwell, R. G., Wilson, J. B., Anderson, S. J. & Longnecker, R. (1998). Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405-411.
4. Chalfie, M. (1995). Green fluorescent protein. Photochemistry and Photobiology 62, 651-656.
5. Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. W. & Prasher, D. C. (1994). Green fluorescent protein as a marker for gene expression. Science 263, 802-805.
6. Chang, R. S. & Lung, M. L. (1994). A modified procedure for the propagation of wild-type Epstein-Barr virus in cultures of marmoset blood cells. Journal of Virological Methods 46, 167-178.
7. Chen, F., Zou, J. Z., di Renzo, L., Winberg, G., Hu, L. F., Klein, E., Klein, G. & Ernberg, I. (1995). A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphona cells in expressing EBNA-1 but not EBNA-2 or LMP1. Journal of Virology 69, 3752-3758.
8. Cormack, B. P., Valdivia, R. H. & Falkow, S. (1996). FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173, 33-38.
9. Fruehling, S. & Longnecker, R. (1997). The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235, 241-251.
10. Fruehling, S., Lee, S. K., Herrold, R., Frech, B., Laux, G., Kremmer, E., Grasser, F. A. & Longnecker, R. (1996). Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. Journal of Virology 70, 6216-6226.
11. Fruehling, S., Swart, R., Dolwick, K. M., Kremmer, E. & Longnecker, R. (1998). Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. Journal of Virology 72, 7796-7806.
12. Heim, R. & Tsien, R. Y. (1996). Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer. Current Biology 6, 178-182.
13. Heim, R., Cubitt, A. B. & Tsien, R. Y. (1995). Improved green fluorescence (letter). Nature 373, 663-664.
14. Herold, B. C., WuDunn, D., Soltys, N. & Spear, P. G. (1991). Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. Journal of Virology 65, 1090-1098.
15. Hummeler, K., Henle, G. & Henle, W. (1966). Fine structure of a virus in cultured lymphoblasts from Burkitt lymphoma. Journal of Bacteriology 91, 1366-1368.
16. Kaye, K. M., Izumi, K. M. & Kieff, E. (1993). Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proceedings of the National Academy of Sciences, USA 90, 9150-9154.
17. Kempkes, B., Pich, D., Zeidler, R. & Hammerschmidt, W. (1995a). Immortalization of human primary B lymphocytes in vitro with DNA. Proceedings of the National Academy of Sciences, USA 92, 5875-5879.
18. Kempkes, B., Pich, D., Zeidler, R., Sugden, B. & Hammerschmidt, W. (1995b). Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA. Journal of Virology 69, 231-238.
19. Kieff, E. (1996). Epstein-Barr virus and its replication. In Fundamental Virology, pp. 1109-1162. Edited by B. Fields, D. Knipe & P. Howley. New York: Raven Press.
20. Kim, O. J. & Yates, J. L. (1993). Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture. Journal of Virology 67, 7634-7640.
21. Klein, G., Lindahl, T., Jondal, M., Leibold, W., Menezes, J., Nilsson, K. & Sundstrom, C. (1974). Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proceedings of the National Academy of Sciences, USA 71, 3283-3286.
22. Klein, G., Clements, G., Zeuthen, J. & Westman, A. (1976). Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle. International Journal of Cancer 17, 715-724.
23. Laux, G., Perricaudet, M. & Farrell, P. J. (1988). A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO Journal 7, 769-774.
24. Laux, G., Economou, A. & Farrell, P. J. (1989). The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region. Journal of General Virology 70, 3079-3084.
25. Longnecker, R. (1998). Molecular biology of Epstein-Barr virus. In Human Tumor Viruses, pp. 133-172. Edited by D. McCance. Washington DC: ASM Press.
26. Longnecker, R. & Miller, C. (1996). Regulation of Epstein-Barr virus latency by latent membrane protein 2. Trends in Microbiology 4, 38-42.
27. Longnecker, R., Druker, B., Roberts, T. M. & Kieff, E. (1991). An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. Journal of Virology 65, 3681-3692.
28. Longnecker, R., Miller, C. L., Miao, X.-Q., Marchini, A. & Kieff, E. (1992). The only domain which distinguishes Epstein-Barr virus latent membrane 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro, and LMP2A is therefore nonessential. Journal of Virology 66, 6461-6469.
29. Longnecker, R., Miller, C. L., Miao, X.-Q., Tomkinson, B. & Kieff, E. (1993a). The last seven transmembrane and carboxy terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro. Journal of Virology 67, 2006-2013.
30. Longnecker, R., Miller, C. L., Tomkinson, B., Miao, X. Q. & Kieff, E. (1993b). Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. Journal of Virology 67, 5068-5074.
31. Marchini, A., Tomkinson, B., Cohen, J. I. & Kieff, E. (1991). BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication. Journal of Virology 65, 5991-6000.
32. Miller, G. & Lipman, M. (1973). Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proceedings of the National Academy of Sciences, USA 70, 190-194.
33. Miller, G., Shope, T., Lisco, H., Stitt, D. & Lipman, M. (1972). Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proceedings of the National Academy of Sciences, USA 69, 383-387.
34. Miller, C. L., Lee, J. H., Kieff, E. & Longnecker, R. (1994). An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proceedings of the National Academy of Sciences, USA 91, 772-776.
35. Miller, C. L., Burkhardt, A. L., Lee, J. H., Stealey, B., Longnecker, R., Bolen, J. B. & Kieff, E. (1995). Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2, 155-166.
36. Miyashita, E. M., Yang, B., Babcock, G. J. & Thorley-Lawson, D. A. (1997). Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. Journal of Virology 71, 4882-4891.
37. Okano, M., Taguchi, Y., Nakamine, H., Pirruccello, S. J., Davis, J. R., Beisel, K. W., Kleveland, K. L., Sanger, W. G., Fordyce, R. R. & Purtilo, D. T. (1990). Characterization of Epstein-Barr virus-induced lympho-proliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice. American Journal of Pathology 137, 517-522.
38. Qu, L. & Rowe, D. (1992). Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. Journal of Virology 66, 3715-3724.
39. Rickinson, A. & Kieff, E. (1996). Epstein-Barr virus. In Fields Virology, 3rd edn, pp. 2397-2446. Edited by B. Fields, D. Knipe & P. Howley. Philadelphia: Lippincott-Raven.
40. Sample, J., Liebowitz, D. & Kieff, E. (1989). Two related Epstein-Barr virus membrane proteins are encoded by separate genes. Journal of Virology 63, 933-937.
41. Sugden, B. & Mark, W. (1977). Clonal transformation of adult human leukocytes by Epstein-Barr virus. Journal of Virology 23, 503-508.
42. Swaminathan, S., Tomkinson, B. & Kieff, E. (1991). Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proceedings of the National Academy of Sciences, USA 88, 1546-1550.
43. Tierney, R. J., Steven, N., Young, L. S. & Rickinson, A. B. (1994). Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. Journal of Virology 68, 7374-7385.
44. Toplin, I. & Schidlovsky, G. (1966). Partial purification and electron microscopy of virus in the EB-3 cell line derived from a Burkitt lymphoma. Science 152, 1084-1085.
45. Vahey, M. T., Wong, M. T. & Michael, N. L. (1995). A standard PCR protocol: rapid isolation of DNA and PCR assay for β-globin. In PCR Primer: A Laboratory Manual, pp. 17-22. Edited by C. W. Dieffenbach & G. S. Dveksler. New York: Cold Spring Harbor Laboratory Press.
46. Wang, F., Marehini, A. & Kieff, E. (1991). Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells. Journal of Virology 65, 1701-1709.